Literature DB >> 12889731

Levels of nicotinamide adenine dinucleotide in extracellular body fluids of pigs may be growth-limiting for Actinobacillus pleuropneumoniae and Haemophilus parasuis.

Terence O'Reilly1, Donald F Niven.   

Abstract

During infection, nutrient deprivation can alter bacterial phenotype. This, in turn, may have implications for pathogenesis and prophylaxis. Actinobacillus pleuropneumoniae (biotype 1) and Haemophilus parasuis, respiratory tract pathogens of swine, are both V-factor-dependent. The concentrations of V factor in the extracellular fluids of pigs are unknown and may limit the growth of these bacteria in vivo. The aim of this study was to determine the concentrations of nicotinamide adenine dinucleotide (NAD) in select porcine body fluids and to compare the availability of NAD in vivo with the affinities of the organisms for this compound. Levels in plasma, tissue fluids (peritoneal, pleural, synovial, and cerebrospinal), and laryngeal, tracheal, and lung washings were determined with an enzymatic cycling assay. We concluded that, although the NAD supply in the respiratory tract is probably not growth-limiting, it may become limiting if the organisms are disseminated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12889731      PMCID: PMC227058     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  20 in total

Review 1.  Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infection.

Authors:  Janine T Bossé; Håkan Janson; Brian J Sheehan; Amanda J Beddek; Andrew N Rycroft; J Simon Kroll; Paul R Langford
Journal:  Microbes Infect       Date:  2002-02       Impact factor: 2.700

2.  Characterization of the in vitro adhesion of Actinobacillus pleuropneumoniae to swine alveolar epithelial cells.

Authors:  Ingrid Van Overbeke; Koen Chiers; Gerard Charlier; Isabel Vandenberghe; Jozef Van Beeumen; Richard Ducatelle; Freddy Haesebrouck
Journal:  Vet Microbiol       Date:  2002-08-02       Impact factor: 3.293

Review 3.  Actinobacillus species and their role in animal disease.

Authors:  A N Rycroft; L H Garside
Journal:  Vet J       Date:  2000-01       Impact factor: 2.688

4.  NAD glycohydrolase: enzyme characterization using intact mammalian erythrocytes.

Authors:  S I Goodman; R J Wyatt; J B Trepel; L M Neckers
Journal:  Comp Biochem Physiol B       Date:  1982

5.  Quantitative extraction and estimation of intracellular nicotinamide nucleotides of Escherichia coli.

Authors:  E M Lilius; V M Multanen; V Toivonen
Journal:  Anal Biochem       Date:  1979-10-15       Impact factor: 3.365

6.  A pyrophosphatase which degrades NAD+ is located on the external surface of cultured fibroblasts: evidence that NAD+ is not extruded during treatment with N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  G S Johnson
Journal:  Arch Biochem Biophys       Date:  1984-03       Impact factor: 4.013

7.  Increased virulence of Neisseria meningitidis after in vitro iron-limited growth at low pH.

Authors:  D Brener; I W DeVoe; B E Holbein
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

8.  Comparative virulence of porcine Haemophilus bacteria.

Authors:  S Rosendal; D A Boyd; K A Gilbride
Journal:  Can J Comp Med       Date:  1985-01

9.  Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells.

Authors:  V Stocchi; L Cucchiarini; M Magnani; L Chiarantini; P Palma; G Crescentini
Journal:  Anal Biochem       Date:  1985-04       Impact factor: 3.365

Review 10.  Physiology aspects of pyridine nucleotide regulation in mammals.

Authors:  C Bernofsky
Journal:  Mol Cell Biochem       Date:  1980-12-16       Impact factor: 3.396

View more
  23 in total

Review 1.  NAD+ utilization in Pasteurellaceae: simplification of a complex pathway.

Authors:  Gabriele Gerlach; Joachim Reidl
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

2.  Differential expression of Haemophilus parasuis genes in response to iron restriction and cerebrospinal fluid.

Authors:  Devon S Metcalf; Janet I MacInnes
Journal:  Can J Vet Res       Date:  2007-07       Impact factor: 1.310

Review 3.  Subcellular compartmentalization of NAD+ and its role in cancer: A sereNADe of metabolic melodies.

Authors:  Yi Zhu; Jiaqi Liu; Joun Park; Priyamvada Rai; Rong G Zhai
Journal:  Pharmacol Ther       Date:  2019-04-08       Impact factor: 12.310

4.  Perception of Damaged Self in Plants.

Authors:  Qi Li; Chenggang Wang; Zhonglin Mou
Journal:  Plant Physiol       Date:  2020-01-06       Impact factor: 8.340

Review 5.  Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)?

Authors:  Carles Cantó; Johan Auwerx
Journal:  Pharmacol Rev       Date:  2011-11-21       Impact factor: 25.468

6.  Emerging functions of extracellular pyridine nucleotides.

Authors:  Richard A Billington; Santina Bruzzone; Antonio De Flora; Armando A Genazzani; Friedrich Koch-Nolte; Mathias Ziegler; Elena Zocchi
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

7.  Vibrio Phage KVP40 Encodes a Functional NAD+ Salvage Pathway.

Authors:  Jae Yun Lee; Zhiqun Li; Eric S Miller
Journal:  J Bacteriol       Date:  2017-04-11       Impact factor: 3.490

Review 8.  NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism.

Authors:  Wusheng Xiao; Rui-Sheng Wang; Diane E Handy; Joseph Loscalzo
Journal:  Antioxid Redox Signal       Date:  2017-07-28       Impact factor: 8.401

Review 9.  The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.

Authors:  Riekelt H Houtkooper; Carles Cantó; Ronald J Wanders; Johan Auwerx
Journal:  Endocr Rev       Date:  2009-12-09       Impact factor: 19.871

10.  Enhanced degradation of dihydrofolate reductase through inhibition of NAD kinase by nicotinamide analogs.

Authors:  Yi-Ching Hsieh; Philip Tedeschi; Rialnat Adebisi Lawal; Debabrata Banerjee; Kathleen Scotto; John E Kerrigan; Kuo-Chieh Lee; Nadine Johnson-Farley; Joseph R Bertino; Emine Ercikan Abali
Journal:  Mol Pharmacol       Date:  2012-11-29       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.